SCHEMBL18045543

SCHEMBL18045543

CNc1cccc(Nc2ccccc2N)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
GAA P10253 5/20 0.62
ALDH1A1 P00352 4/20 0.62
KDM4E B2RXH2 4/20 0.62
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
LMNA P02545 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.58
RAB9A P51151 2/20 0.58
TDP1 Q9NUW8 3/20 0.55
TP53 P04637 1/20 0.53
APP P05067 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
SNCA P37840 1/20 0.53
BLM P54132 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7166997 0.90 MAPT (0.75) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL2931765 0.82 MAPT (0.74) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL4945848 0.81 MAPT (0.65) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL7389020 0.81 MAPT (0.67) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL7171246 0.81 MAPT (0.67) MAPTGAAALDH1A1KDM4EMEN1
Methane SCHEMBL28002260 0.79 MAPT (0.64) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL4716263 0.78 MAPT (0.63) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL4054374 0.78 MAPT (0.62) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL9559159 0.78 MAPT (0.62) MAPTGAAALDH1A1KDM4EMEN1
SCHEMBL29414653 0.78 MAPT (0.63) MAPTGAAALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3159737-B1 LIQUID CRYSTAL DISPLAY ELEMENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT TREATMENT AGENT NISSAN CHEMICAL CORP (JP) 2021-05-26 EP disclosed
US-10023530-B2 Diamine, polyamic acid, and polyimide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-07-17 US disclosed
US-20170184923-A1 LIQUID CRYSTAL DISPLAY ELEMENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT TREATMENT AGENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-06-29 US disclosed
US-20160264520-A1 NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE NISSAN CHEMICAL INDUSTRIES. LTD. (JP) 2016-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023530-B2 Diamine, polyamic acid, and polyimide H1-2, H1-4, H1-0 MAPT 3277/4885GAA 3810/4885ALDH1A1 1921/4885
US-20160264520-A1 NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE H1-4, H1-2, H1-5 MAPT 3086/4885GAA 3782/4885ALDH1A1 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.